Alticor Enters Into Joint Venture Agreement With Metagenics

    Metagenics to Operate as a Stand-Alone Entity Serving Health Care

    Companies Share a Philosophy of Promoting Science-Based Nutrition and
    Healthy Living

    ADA, Mich. and SAN CLEMENTE, Calif., Aug. 11 /CNW/ -- Alticor, a global
company with an uncompromising commitment to innovative scientific research
and development of quality products, and Metagenics, a premier manufacturer
and distributor of science-based medical foods and nutraceuticals marketed to
health care professionals, today announced that they have entered into a joint
venture agreement.

    Under the terms of the agreement, Alticor will obtain a substantial
ownership interest in Metagenics, and the current Metagenics shareholders will
continue to retain a significant interest in the company.  The agreement is
subject to customary closing conditions, including approval by Metagenics
shareholders and antitrust clearance.  The closing is expected to take place
later this summer. Detailed terms of the agreement were not disclosed.

    "Today is an extraordinary day for Metagenics and its employees and
customers around the world as we join forces with a partner that shares our
commitment to science-based nutrition and wellness," said Jeffrey J. Katke,
Chairman and CEO of Metagenics.  "Alticor is an $8 billion global company with
an unwavering dedication to research and the development of best-in-class
products. We are confident that this joint venture will give Metagenics new
opportunities to expand and grow - allowing us to further enhance the
innovative product offerings our trusted health care professionals have come
to expect."

    Katke added, "Metagenics remains dedicated to its values. We believe this
joint venture, by giving us access to financial resources to support our
internal growth and our acquisition strategy, will help Metagenics realize its
vision of reversing the chronic illness epidemic. Metagenics will continue to
operate as a stand-alone company, delivering medical foods and nutraceuticals
through health care professionals around the world."

    "Alticor and Metagenics share a philosophy for promoting good nutrition,
healthy living and natural science," said Jim Weaver, Vice President - Alticor
Corporate Enterprises. "Each company boasts a deep commitment to science and
nature with leading research and development teams dedicated to harnessing the
power of plant-based, natural, scientific research. This joint venture fits
into our strategy to bring complementary brands into our family of businesses,
and we are pleased to be partnering with Metagenics' world-class employees and
management team."

    Alticor and Metagenics each have a long history of dedication to health,
wellness and the application of advanced science and technology.

    Alticor, through its NUTRILITE(TM) brand, conducts innovative nutrition
research and offers more than 200 products to address the individual
nutritional and wellness needs of anyone at any life stage. Many of
NUTRILITE's products are manufactured using botanicals grown either on
NUTRILITE-owned certified organic farms or on farms that adhere to sustainable
farming principles to ensure the best products are delivered to individuals
seeking to maintain a healthy lifestyle.

    Metagenics' investment in scientific research led to the development of
its leading nutrigenomic research center. The center develops science-based
medical foods and nutraceuticals for nutritional support of clinically tested
therapeutic lifestyle-change programs. Therapeutic lifestyle change programs
are emerging as the preferred method for the treatment and prevention of
chronic illnesses.

    In forming the joint venture, Bryan Cave provided legal counsel for
Alticor and Crowe Horwath served as financial advisors. Canaccord Adams acted
as exclusive financial adviser to Metagenics, and McDermott Will & Emery
provided legal counsel.

    About Alticor

    Alticor ( is the parent company of Amway Corp., Amway
Global, Access Business Group LLC and Alticor Corporate Enterprises.
Headquartered in Ada, Michigan, USA, Alticor and its affiliates offer
products, business opportunities, and product development, manufacturing and
logistic services in more than 80 countries and territories worldwide. In its
most recent financial year, the company reported worldwide sales of more than
$8.2 billion. For further information, please contact Alticor's media
information line at 616-787-7565 or e-mail Alticor's media relations staff at

    Ania Zdrada
    Corporate Communications

    About Metagenics

    Metagenics ( headquartered in San Clemente, CA, is a
global life sciences company focused on reversing chronic illness and
improving health. Founded in 1983, the company serves tens of thousands of
health care professionals and more than a million patients throughout the
world and holds more than 40 proprietary formula patents for use in
nutraceuticals, medical foods, and pharmaceuticals. Today, Metagenics
continues its leadership role through its world class sales force, by
successfully merging the disciplines of nutritional genomics, functional
medicine, and therapeutic lifestyle change programs to find solutions to
society's most pressing health concerns.

    Joseline L. Davison
    Corporate Communications
    Metagenics, Inc.


For further information:

For further information: Ania Zdrada, Corporate Communications, Alticor,, +1-616-787-7565; or Joseline L. Davison, Corporate
Communications, Metagenics, Inc.,, +1-949-369-3406
Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890